Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 595-601

  Lee, Chang Kwon ^a   Minami, Masashi ^a   Sakuda, Shohei ^a   Nihira, Takuya ^a   Yamada, Yasuhiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

16 DIHYDROVIRGINIAMYCIN M1; ANTIBIOTIC AGENT; CARBONYL DERIVATIVE; DALFOPRISTIN; HYDROXYL GROUP; METHYL GROUP; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; VIRGINIAMYCIN S;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG STRUCTURE; IRRADIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; REDUCTION; STEREOSPECIFICITY; STREPTOMYCES;

EID: 0029915767     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.595     Document Type: Article

References (16)

1. Biot, A. M. 1984. Virginiamycin: properties, biosynthesis, and fermentation, p. 695-720- In E. J. Vandamme (ed.), Biotechnology of industrial antibiotics. Marcel Dekker, Inc., New York.
2. Cocito, C. 1979. Antibiotics of the virgimamycin family, inhibitors which contain synergistic compounds Microbiol Rev 43:145-198.
3. 2 J. Chem. Soc. 1966:1653-1669.
4. De Meester, C., and J. Rondelet. 1976. Microbial acetylation of M factor of virgimamycin. J Antibiot. 29:1297-1305
5. 13C NMR chemical shift correlations in 1,3-diol acetonides. Implications for the stcreochemical assignment of propionate-derived polyols. Tetrahedron Lett. 131:7099-7100.
6. Kim, C. H., T. Endo, and H. Yonehara. 1976 Purification and some properties of mikamycin B lactonase. Agric. Biol. Chem. 40:1559-1564.
7. Kim, C. H., N. Otake, and H. Yonehara. 1974. Studies on mikamycin B lactonase. I. Degradation of mikamycin B by Streplomyces mitakaensis. J. Antibiot. 27:903-908.
8. Kim, H.-S., T. Nihira, H. Tada, M. Yanagimoto, and Y. Yamada. 1989. Identification of binding protein of virginiae butanolide C, an autoregulator in virginiamycin production, from Streptomyces virginiae. J. Antibiot. 42:769-778.
9. Kingston, D. G. I., L. Todd, and D. H. Williams. 1966. Antibiotics of the ostreogrycin complex. Part III. The structure of ostreogrycin A. Evidence based on nuclear magnetic double resonance experiments and high-resolution mass spectrometry J. Chem. Soc. 1966:1669-1676
10. Kitamura, M., M. Isobe, Y. Ichikawa, and T. Goto. 1984. Stereocontrolled total synthesis of (-)-maytansinol. J. Am. Chem. Soc. 106:3252-3257.
11. Le Gome, F., M. L. Capmau, K. L. Bonnet, C. Cerceau, C. J. Soussy, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PACHA, a new enzyme which modifies pristinamycin IIA. J. Antibiot. 30: 665-669.
12. Paris, J. M., J. C. Barriere, C. Smith, and P. E. Bost. 1990. The chemistry of pristinamycins, p. 183-248. In G. Lukacs and M. Ohno (ed.), Recent progress in the chemical synthesis of antibiotics Springer-Verlag, Berlin.
13. 13C NMR analysis of 1,3-diol acetonides. Tetrahedron Lett. 131:945-948
14. Rychnovsky, S. D., D. J. Skalitzky, C. Pathirana, P. R. Jensen, and W. Fenical. 1992. Stereochemistry of the macrolactins J. Am. Chem. Soc. 114: 671-677.
15. Sakuda, S., and Y. Yamada. 1991 Stereochemistry of butyrolactone autoregulators from Streptomyces Tetrahedron Lett. 132:1817-1820
16. Yamada, Y., K. Sugamura, K. Kondo, M. Yanagimoto, and H. Okada. 1987. The structure of inducing factors for Virginiamycin production in Strepiomyces virgimae J Antibiot. 40:496-504.